Canine autoimmune hemolytic anemia: management challenges

James W Swann,1 Barbara J Skelly2 1Queen Mother Hospital for Animals, The Royal Veterinary College, Hatfield, Hertfordshire, 2Department of Veterinary Medicine, University of Cambridge, Cambridge, UK Abstract: Immune-mediated hemolytic anemia is one of the most common manifestations of canine immune...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Swann JW, Skelly BJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	IMHA canine immune-mediated disease management regimens Veterinary medicine SF600-1100
Acceso en línea:	https://doaj.org/article/58c8009425d64f07922ffca840e09c10
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:58c8009425d64f07922ffca840e09c10
record_format	dspace
spelling	oai:doaj.org-article:58c8009425d64f07922ffca840e09c102021-12-02T00:15:35ZCanine autoimmune hemolytic anemia: management challenges2230-2034https://doaj.org/article/58c8009425d64f07922ffca840e09c102016-07-01T00:00:00Zhttps://www.dovepress.com/canine-autoimmune-hemolytic-anemia-management-challenges-peer-reviewed-article-VMRRhttps://doaj.org/toc/2230-2034James W Swann,1 Barbara J Skelly2 1Queen Mother Hospital for Animals, The Royal Veterinary College, Hatfield, Hertfordshire, 2Department of Veterinary Medicine, University of Cambridge, Cambridge, UK Abstract: Immune-mediated hemolytic anemia is one of the most common manifestations of canine immune-mediated disease, yet treatment regimens remain nonstandardized and, in some cases, controversial. The main reason for this, as for most diseases in veterinary medicine, is the lack of large-scale placebo-controlled trials so that the efficacy of one treatment over another can be established. Most of the evidence used for treatment comes from retrospective studies and from personal preference and experience, and because of this, treatment regimens tend to vary among institutions and individual clinicians. Management of immune-mediated hemolytic anemia includes immunosuppression, thromboprophylaxis, and supportive care measures to help prevent and treat concurrent conditions. Keywords: IMHA, canine immune-mediated disease, management regimensSwann JWSkelly BJDove Medical PressarticleIMHAcanine immune-mediated diseasemanagement regimensVeterinary medicineSF600-1100ENVeterinary Medicine: Research and Reports, Vol 2016, Iss Issue 1, Pp 101-112 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	IMHA canine immune-mediated disease management regimens Veterinary medicine SF600-1100
spellingShingle	IMHA canine immune-mediated disease management regimens Veterinary medicine SF600-1100 Swann JW Skelly BJ Canine autoimmune hemolytic anemia: management challenges
description	James W Swann,1 Barbara J Skelly2 1Queen Mother Hospital for Animals, The Royal Veterinary College, Hatfield, Hertfordshire, 2Department of Veterinary Medicine, University of Cambridge, Cambridge, UK Abstract: Immune-mediated hemolytic anemia is one of the most common manifestations of canine immune-mediated disease, yet treatment regimens remain nonstandardized and, in some cases, controversial. The main reason for this, as for most diseases in veterinary medicine, is the lack of large-scale placebo-controlled trials so that the efficacy of one treatment over another can be established. Most of the evidence used for treatment comes from retrospective studies and from personal preference and experience, and because of this, treatment regimens tend to vary among institutions and individual clinicians. Management of immune-mediated hemolytic anemia includes immunosuppression, thromboprophylaxis, and supportive care measures to help prevent and treat concurrent conditions. Keywords: IMHA, canine immune-mediated disease, management regimens
format	article
author	Swann JW Skelly BJ
author_facet	Swann JW Skelly BJ
author_sort	Swann JW
title	Canine autoimmune hemolytic anemia: management challenges
title_short	Canine autoimmune hemolytic anemia: management challenges
title_full	Canine autoimmune hemolytic anemia: management challenges
title_fullStr	Canine autoimmune hemolytic anemia: management challenges
title_full_unstemmed	Canine autoimmune hemolytic anemia: management challenges
title_sort	canine autoimmune hemolytic anemia: management challenges
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/58c8009425d64f07922ffca840e09c10
work_keys_str_mv	AT swannjw canineautoimmunehemolyticanemiamanagementchallenges AT skellybj canineautoimmunehemolyticanemiamanagementchallenges
_version_	1718403867733917696

Canine autoimmune hemolytic anemia: management challenges

Ejemplares similares